Search research articles
Contact Us
Filters
Showing results (271-280 of 545) with videos related to
Page
of 55
Sort By:
Transfusion Science
|
May 7, 1998
Computer assisted prospective review of blood product utilization: a large hospital experience
V A Silva, D H Vroon
Transfusion Science
|
May 7, 1998
Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy
A R Giles, G E Rivard, J Teitel, et al.
Transfusion Science
|
May 7, 1998
Clinical use of recombinant FVIIa (rFVIIa)
U Hedner, J Ingerslev
Transfusion Science
|
May 7, 1998
Stem cells: what's happening? Focus on quality assurance, GMP and regulatory aspects
M J Seghatchian
Transfusion Science
|
August 6, 1994
International forum: The U.K. A forum discussion on circles of dependence of quality in the blood transfusion community
Transfusion Science
|
August 5, 1996
A multicentre prospective cohort study of immune function in patients treated with monoclonally immunopurified or resin-purified SNBTS high-potency factor VIII concentrate
C R Hay
Transfusion Science
|
May 7, 1997
A workshop and symposium on haemopoietic stem cells. 16th April 1996
M J Seghatchian, H Bessos
Transfusion Science
|
October 28, 1999
Quantitative PCR for counting residual white blood cells in blood products
T J Legler, J Riggert, G Dove, et al.
Transfusion Science
|
June 7, 1993
LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia
J Thiery, D Seidel
Transfusion Science
|
June 7, 1993
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992
B R Gordon, S D Saal
Page
of 55
Search research articles
Search
Showing results (271-280 of 545) with videos related to
Sort By:
Page
of 55
Transfusion Science
|
May 7, 1998
Computer assisted prospective review of blood product utilization: a large hospital experience
V A Silva, D H Vroon
Transfusion Science
|
May 7, 1998
Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy
A R Giles, G E Rivard, J Teitel, et al.
Transfusion Science
|
May 7, 1998
Clinical use of recombinant FVIIa (rFVIIa)
U Hedner, J Ingerslev
Transfusion Science
|
May 7, 1998
Stem cells: what's happening? Focus on quality assurance, GMP and regulatory aspects
M J Seghatchian
Transfusion Science
|
August 6, 1994
International forum: The U.K. A forum discussion on circles of dependence of quality in the blood transfusion community
Transfusion Science
|
August 5, 1996
A multicentre prospective cohort study of immune function in patients treated with monoclonally immunopurified or resin-purified SNBTS high-potency factor VIII concentrate
C R Hay
Transfusion Science
|
May 7, 1997
A workshop and symposium on haemopoietic stem cells. 16th April 1996
M J Seghatchian, H Bessos
Transfusion Science
|
October 28, 1999
Quantitative PCR for counting residual white blood cells in blood products
T J Legler, J Riggert, G Dove, et al.
Transfusion Science
|
June 7, 1993
LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia
J Thiery, D Seidel
Transfusion Science
|
June 7, 1993
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992
B R Gordon, S D Saal
Page
of 55